Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascorbyl glucoside is a stable analog of vitamin C, naturally found in the fruit of *Lycium barbarum L.*. It exhibits antioxidant properties and has demonstrated cytotoxic and antiproliferative effects against cancer cells, specifically HeLa cells, in vitro. Its mechanism of action in cancer cells involves inducing apoptosis and cell cycle arrest, primarily by stabilizing the p53 protein. It also mediates antitumor activity by downregulating proteins involved in cell apoptosis and proliferation. Ascorbyl glucoside is being investigated for its role in mediating microbiome rebalance and reducing dandruff when formulated in topical lotions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ascorbyl glucoside.